# Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients

> **NCT02575859** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 20 (actual)

## Conditions studied

- Colorectal Neoplasm
- Metastasis

## Interventions

- **DRUG:** adjuvant HIPEC
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT02575859
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2010-06
- **Final completion:** 2011-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02575859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02575859, "Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02575859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*